Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Cardiovascular Diabetology, 2022
Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project

Korduner J., Holm H., Jujic A. et al.

Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma

Cell Reports Medicine, 2022
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19

Feyaerts D., Hédou J., Gillard J. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyPatient StratificationPlasma

Clinical Infectious Diseases, 2022
Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity

Morrocchi E., Pighi C., Pascucci G. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Journal of Cardiovascular Translational Research, 2022
Screening for Biomarkers Associated with Left Ventricular Function During Follow-up After Acute Coronary Syndrome

Christersson C., Baron T., Flachskampf F. et al.

Olink Target 96CVDPathophysiologyPlasma

iScience, 2022
Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Buyukozkan M., Alvarez-Mulett S., Racanelli A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationSerum

Brain and Spine, 2022
Cerebrospinal fluid and peripheral blood proteomics in Traumatic Spinal Cord Injury: A prospective pilot study

Wichmann T., Kasch H., Dyrskog S. et al.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

Brain Communications, 2022
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

Kivisäkk P., Magdamo C., Trombetta B. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Scientific Reports, 2022
Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis

Pallares Robles A., ten Cate V., Schulz A. et al.

Olink Target 96CVDPathophysiologyPlasma

Nature Biotechnology, 2022
Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

Schwarz M., Torre D., Lozano-Ojalvo D. et al.

Olink Target 48Infectious DiseasesTechnical EvaluationPlasma

Scientific Reports, 2022
Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study

Dlamini S., Norris S., Mendham A. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

European Journal of Endocrinology, 2022
Novel inflammatory biomarkers in thyroid eye disease

Ueland H., Ueland G., Løvås K. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Arthritis & Rheumatology, 2022
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel

Loza M., Nagpal S., Cole S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Nature Communications, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Damsky W., Wang A., Kim D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Communications Biology, 2022
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort

Yang J., Jia Z., Song X. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

Frontiers in Neurology, 2022
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease

Carlyle B., Kitchen R., Mattingly Z. et al.

Olink Target 96NeurologyTechnical EvaluationPlasma

Nature Medicine, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Padrón L., Maurer D., O’Hara M. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

BMC Women's Health, 2022
Applicability of polygenic risk scores in endometriosis clinical presentation

Svensson A., Garcia-Etxebarria K., Åkesson A. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationSerum

Brain, 2022
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease

Bottigliengo D., Foco L., Seibler P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Kidney Medicine, 2022
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationPlasma

Scandinavian Journal of Immunology, 2022
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

Ljunggren H., Heggernes Ask E., Cornillet M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

3478 publications